Quantum-Si (NASDAQ:QSI) Stock Price Down 5.2% – Here’s Why

Quantum-Si Incorporated (NASDAQ:QSI)’s stock price was down 5.2% on Tuesday . The company traded as low as $0.9353 and last traded at $0.9388. Approximately 3,528,987 shares were traded during mid-day trading, a decline of 25% from the average daily volume of 4,678,401 shares. The stock had previously closed at $0.9906.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on QSI shares. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Quantum-Si in a research report on Monday, December 29th. Canaccord Genuity Group lowered their target price on Quantum-Si from $2.00 to $1.50 and set a “hold” rating for the company in a report on Monday, December 22nd. Two equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Quantum-Si presently has an average rating of “Hold” and an average target price of $3.55.

Quantum-Si Stock Performance

The company has a 50 day moving average of $1.19 and a two-hundred day moving average of $1.40. The stock has a market capitalization of $202.30 million, a PE ratio of -1.40 and a beta of 2.98.

Insider Activity

In other Quantum-Si news, insider John S. Vieceli sold 21,927 shares of the company’s stock in a transaction that occurred on Monday, December 22nd. The shares were sold at an average price of $1.28, for a total transaction of $28,066.56. Following the transaction, the insider owned 800,973 shares in the company, valued at approximately $1,025,245.44. This represents a 2.66% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Jeffrey Alan Hawkins sold 23,707 shares of the firm’s stock in a transaction on Monday, December 22nd. The stock was sold at an average price of $1.28, for a total transaction of $30,344.96. Following the completion of the transaction, the chief executive officer directly owned 2,578,018 shares of the company’s stock, valued at approximately $3,299,863.04. This represents a 0.91% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 54,261 shares of company stock worth $69,454. Corporate insiders own 22.95% of the company’s stock.

Institutional Trading of Quantum-Si

Several large investors have recently made changes to their positions in the business. Millennium Management LLC purchased a new position in shares of Quantum-Si during the 1st quarter valued at about $4,721,000. State Street Corp raised its position in Quantum-Si by 26.5% during the fourth quarter. State Street Corp now owns 3,562,721 shares of the company’s stock valued at $3,919,000 after acquiring an additional 745,231 shares in the last quarter. Squarepoint Ops LLC purchased a new position in Quantum-Si during the third quarter valued at approximately $865,000. Geode Capital Management LLC lifted its holdings in Quantum-Si by 15.1% in the second quarter. Geode Capital Management LLC now owns 3,447,738 shares of the company’s stock valued at $6,759,000 after acquiring an additional 452,850 shares during the period. Finally, Bank of America Corp DE boosted its position in Quantum-Si by 426.6% in the 2nd quarter. Bank of America Corp DE now owns 465,999 shares of the company’s stock worth $913,000 after purchasing an additional 377,504 shares in the last quarter. 39.90% of the stock is owned by hedge funds and other institutional investors.

Quantum-Si Company Profile

Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.

Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.